Article

Omicron-Specific and Bivalent Omicron-Containing Vaccine Candidates Elicit Potent Virus Neutralisation in the Animal Model

2022-02-15

Abstract excerpt

<h4>Background</h4> Omicron variant (B. 1.1.529) is able to escape from naturally acquired and vaccine-induced immunity, which mandates updating the current COVID-19 vaccines. Here, we investigated and compared the neutralising antibody induction of the ancestral variant-based BIV1-CovIran vaccine, the Omicron variant-based BIV1-CovIran Plus vaccine, and the novel bivalent vaccine candidate, BBIV1-CovIran, agains...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0b339b8b-66bc-5d38-9a1b-587ab3cb7463
DOI: 10.1101/2022.02.11.480131

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Omicron-Specific and Bivalent Omicron-Containing Vaccine Candidates Elicit Potent Virus Neutralisation in the Animal ModelDOI 10.1101/2022.02.11.480131Read

Sub-optimal Neutralisation of Omicron (B.1.1.529) Variant by Antibodies induced by Vaccine alone or SARS-CoV-2 Infection plus Vaccine (Hybrid Immunity) post 6-monthsSemantic proximity Read

mRNA vaccines and hybrid immunity use different B cell germlines to neutralize Omicron BA.4 and BA.5Semantic proximity Read

Increasing SARS-CoV-2 mutations against vaccination-acquired immunitySemantic proximity Read

Post-vaccination neutralization responses to Omicron sub-variantsSemantic proximity Read

Three doses of the BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 B.1.1.529 (Omicron) variant of concernSemantic proximity Read

Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron subvariants BA.2, BA.2.12.1 and BA.5Semantic proximity Read

Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariantsSemantic proximity Read

Inactivated Whole Virion Vaccine Protects K18-hACE2 Tg Mice Against Omicron SARS-CoV-2 Variant Via Cross-Reactive T Cells and Non-Neutralizing Antibody ResponsesSemantic proximity Read

Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron VOCsSemantic proximity Read

Evaluation of the cross reactivity of neutralising antibody response in vaccinated human and convalescent hamster sera against SARS-CoV-2 variants up to and including JN.1 using an authentic virus neutralisation assaySemantic proximity Read

A neutralizing antibody protects Kunming mice against AKAV lethal challengeSemantic proximity Read

Pathogenicity of SARS-CoV-2 Omicron in Syrian hamsters and its neutralization with different Variants of ConcernSemantic proximity Read